Rhenman & Partners Asset Management AB as of March 31, 2018
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 92 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 3.5 | $29M | 2.0M | 14.20 | |
| Celgene Corporation | 3.3 | $26M | 296k | 89.21 | |
| Alexion Pharmaceuticals | 3.0 | $25M | 222k | 111.46 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $24M | 150k | 162.98 | |
| Jazz Pharmaceuticals (JAZZ) | 2.8 | $22M | 148k | 150.99 | |
| Abiomed | 2.7 | $22M | 77k | 290.99 | |
| Bristol Myers Squibb (BMY) | 2.7 | $22M | 350k | 63.25 | |
| Nektar Therapeutics (NKTR) | 2.7 | $22M | 208k | 106.26 | |
| Exelixis (EXEL) | 2.7 | $22M | 986k | 22.15 | |
| Abbvie (ABBV) | 2.4 | $20M | 207k | 94.65 | |
| CIGNA Corporation | 2.3 | $19M | 110k | 167.74 | |
| Humana (HUM) | 2.2 | $18M | 68k | 268.82 | |
| Gilead Sciences (GILD) | 2.2 | $18M | 237k | 75.39 | |
| Esperion Therapeutics (ESPR) | 2.2 | $18M | 245k | 72.33 | |
| UnitedHealth (UNH) | 2.1 | $17M | 81k | 214.00 | |
| Eli Lilly & Co. (LLY) | 2.1 | $17M | 223k | 77.37 | |
| Medtronic (MDT) | 2.1 | $17M | 211k | 80.22 | |
| Intra Cellular Therapies (ITCI) | 2.1 | $17M | 793k | 21.05 | |
| BioMarin Pharmaceutical (BMRN) | 2.0 | $17M | 205k | 81.07 | |
| Becton, Dickinson and (BDX) | 2.0 | $16M | 75k | 216.71 | |
| Iovance Biotherapeutics (IOVA) | 2.0 | $16M | 944k | 16.90 | |
| CVS Caremark Corporation (CVS) | 1.9 | $16M | 254k | 62.21 | |
| Glaukos (GKOS) | 1.9 | $16M | 503k | 30.83 | |
| Sage Therapeutics (SAGE) | 1.9 | $15M | 95k | 161.07 | |
| Express Scripts Holding | 1.8 | $15M | 215k | 69.08 | |
| Anthem (ELV) | 1.6 | $13M | 61k | 219.70 | |
| Incyte Corporation (INCY) | 1.6 | $13M | 159k | 83.33 | |
| Abbott Laboratories (ABT) | 1.5 | $12M | 202k | 59.92 | |
| Regeneron Pharmaceuticals (REGN) | 1.4 | $12M | 34k | 344.35 | |
| Edwards Lifesciences (EW) | 1.4 | $12M | 83k | 139.52 | |
| Biogen Idec (BIIB) | 1.4 | $12M | 42k | 273.83 | |
| Array BioPharma | 1.4 | $11M | 702k | 16.32 | |
| Arena Pharmaceuticals | 1.4 | $11M | 286k | 39.50 | |
| Allergan | 1.2 | $10M | 60k | 168.28 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $10M | 84k | 119.09 | |
| Boston Scientific Corporation (BSX) | 1.2 | $9.5M | 348k | 27.32 | |
| Novocure Ltd ord (NVCR) | 1.2 | $9.5M | 435k | 21.80 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $9.1M | 110k | 82.93 | |
| AmerisourceBergen (COR) | 1.1 | $9.0M | 104k | 86.21 | |
| Xencor (XNCR) | 1.1 | $9.0M | 300k | 29.98 | |
| Portola Pharmaceuticals | 1.1 | $8.8M | 270k | 32.66 | |
| Loxo Oncology | 1.1 | $8.7M | 75k | 115.37 | |
| Myokardia | 1.0 | $8.2M | 168k | 48.80 | |
| Fibrogen (FGEN) | 1.0 | $7.8M | 170k | 46.20 | |
| Agios Pharmaceuticals (AGIO) | 1.0 | $7.8M | 95k | 81.78 | |
| Macrogenics (MGNX) | 0.9 | $7.5M | 300k | 25.16 | |
| Centene Corporation (CNC) | 0.9 | $6.9M | 65k | 106.88 | |
| Seattle Genetics | 0.8 | $6.8M | 130k | 52.34 | |
| Revance Therapeutics (RVNC) | 0.8 | $6.3M | 203k | 30.80 | |
| Immunomedics | 0.8 | $6.1M | 415k | 14.61 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $6.1M | 270k | 22.47 | |
| Rigel Pharmaceuticals (RIGL) | 0.7 | $5.7M | 1.6M | 3.54 | |
| Alkermes (ALKS) | 0.7 | $5.3M | 91k | 57.96 | |
| Flexion Therapeutics | 0.7 | $5.3M | 237k | 22.41 | |
| Adamas Pharmaceuticals | 0.6 | $5.0M | 210k | 23.90 | |
| Walgreen Boots Alliance (WBA) | 0.6 | $4.9M | 75k | 65.47 | |
| Sangamo Biosciences (SGMO) | 0.6 | $4.9M | 256k | 19.00 | |
| Spark Therapeutics | 0.6 | $4.5M | 68k | 66.58 | |
| Livanova Plc cmn | 0.6 | $4.4M | 50k | 88.50 | |
| Coherus Biosciences (CHRS) | 0.5 | $3.9M | 350k | 11.05 | |
| Endologix | 0.5 | $3.8M | 906k | 4.23 | |
| Medicines Company | 0.4 | $3.3M | 100k | 32.94 | |
| Epizyme | 0.4 | $3.2M | 181k | 17.75 | |
| Omnicell (OMCL) | 0.3 | $2.5M | 58k | 43.41 | |
| Achillion Pharmaceuticals | 0.3 | $2.5M | 668k | 3.71 | |
| Aerie Pharmaceuticals | 0.3 | $2.2M | 40k | 54.25 | |
| Viewray (VRAYQ) | 0.3 | $2.1M | 332k | 6.43 | |
| Zogenix | 0.2 | $2.0M | 50k | 40.06 | |
| Pieris Pharmaceuticals (PIRS) | 0.2 | $2.0M | 300k | 6.82 | |
| Chimerix (CMRX) | 0.2 | $1.8M | 342k | 5.20 | |
| Newlink Genetics Corporation | 0.2 | $1.3M | 181k | 7.25 | |
| Keryx Biopharmaceuticals | 0.1 | $1.2M | 302k | 4.09 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $1.2M | 450k | 2.72 | |
| Dermira | 0.1 | $759k | 95k | 7.99 | |
| Adverum Biotechnologies | 0.1 | $737k | 127k | 5.80 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $636k | 8.5k | 74.60 | |
| Halliburton Company (HAL) | 0.1 | $688k | 15k | 46.93 | |
| JPMorgan Chase & Co. (JPM) | 0.1 | $593k | 5.4k | 110.00 | |
| International Business Machines (IBM) | 0.1 | $579k | 3.8k | 153.46 | |
| Janus Henderson Group Plc call | 0.1 | $591k | 18k | 33.09 | |
| Microsoft Corporation (MSFT) | 0.1 | $499k | 5.5k | 91.31 | |
| Walt Disney Company (DIS) | 0.1 | $463k | 4.6k | 100.37 | |
| Chevron Corporation (CVX) | 0.1 | $473k | 4.1k | 114.03 | |
| Ford Motor Company (F) | 0.1 | $472k | 43k | 11.08 | |
| Anheuser-Busch InBev NV (BUD) | 0.1 | $463k | 4.2k | 110.00 | |
| Qualcomm (QCOM) | 0.1 | $446k | 8.1k | 55.39 | |
| Pfizer (PFE) | 0.0 | $311k | 8.8k | 35.53 | |
| Wells Fargo & Company (WFC) | 0.0 | $307k | 5.9k | 52.41 | |
| STAAR Surgical Company (STAA) | 0.0 | $365k | 25k | 14.80 | |
| Symantec Corporation | 0.0 | $363k | 14k | 25.86 | |
| Regulus Therapeutics | 0.0 | $355k | 493k | 0.72 | |
| Ra Pharmaceuticals | 0.0 | $208k | 39k | 5.32 |
